The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that Celera Corporation, a leading healthcare company, has listed its common stock on The NASDAQ Stock Market. Celera was previously a tracking stock of Applera Corp (NYSE:CRA) traded on the NYSE. It will begin trading on NASDAQ today using the same symbol, CRA.
"Celera is a true innovator in the healthcare space and we are very pleased to welcome them to the NASDAQ OMX family," said Magnus Bocker, President, NASDAQ OMX Group, Inc. "NASDAQ is home to the biotech industry, and Celera as an industry leader will join the ranks of companies who have redefined how we look at healthcare."
About Celera
Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and optimize patient management.
Celera also commercializes a wide range of molecular diagnostic products through its strategic alliance with Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. -- www.nasdaq.com
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
